Atazanavir pharmacokinetics with and without tenofovir during pregnancy.

MLA

Mirochnick, Mark, et al. “Atazanavir Pharmacokinetics with and without Tenofovir during Pregnancy.” Journal of Acquired Immune Deficiency Syndromes (1999), vol. 56, no. 5, Apr. 2011, pp. 412–19. EBSCOhost, https://doi.org/10.1097/QAI.0b013e31820fd093.

APA

Mirochnick, M., Best, B. M., Stek, A. M., Capparelli, E. V., Hu, C., Burchett, S. K., Rossi, S. S., Hawkins, E., Basar, M., Smith, E., & Read, J. S. (2011). Atazanavir pharmacokinetics with and without tenofovir during pregnancy. Journal of Acquired Immune Deficiency Syndromes (1999), 56(5), 412–419. https://doi.org/10.1097/QAI.0b013e31820fd093

Chicago

Mirochnick, Mark, Brookie M Best, Alice M Stek, Edmund V Capparelli, Chengcheng Hu, Sandra K Burchett, Steven S Rossi, et al. 2011. “Atazanavir Pharmacokinetics with and without Tenofovir during Pregnancy.” Journal of Acquired Immune Deficiency Syndromes (1999) 56 (5): 412–19. doi:10.1097/QAI.0b013e31820fd093.